An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

"Nothing we've tested before has compared to semaglutide's ability to decrease appetite and body weight ... to gain a deeper understanding of the molecular pathways it influences.

While people lost more weight on tirzepatide than semaglutide, it’s still a significant amount of weight, since research considers effective weight loss of more than 5% of body weight after 12 ...

The study focused primarily on semaglutide formulations for diabetes (e.g., Ozempic), as data for the obesity-specific formulation Wegovy were limited. Rapid weight loss (>10% body weight in 6 ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

reflect weight loss of at least 5% with three months of semaglutide treatment. 13-15 This is comparable to that seen in premenopausal women despite higher initial body weight and fat mass in ...

A 2021 study found that, on average, people lost more than 2% of their body weight in the first 4 weeks of using semaglutide. (Semaglutide is the active ingredient in Wegovy.) For example ...

"We are fortunate to have timed this release during industry downturn and economic challenges alongside the disruption to non-invasive body contouring demand by that of semaglutide and the heavily ...